Name | Inaxaplin |
---|
Description | Inaxaplin is an apolipoprotein L1 (APOL1) function inhibitor (WO2020131807, compound 2). Inaxaplin can be used for the research of kidney disease[1]. |
---|---|
Related Catalog | |
Target |
APOL1[1] |
In Vitro | Inaxaplin is an apolipoprotein L1 function inhibitor[1]. |
References |
[1]. WO2020131807 |
Molecular Formula | C21H18F3N3O3 |
---|---|
Molecular Weight | 417.38 |